NESTEC / Clinical Development Unit / Metabolic Unit
Lausanne, Canton of Vaud, 1000, Switzerland
NCT Number: NCT01287403
Cereal grains contain a wide variety of different phytochemicals which may play different roles in physiology. Their response in plasma and urine after a meal is poorly defined for most cereals. This study will investigate the plasma response and urinary excretion of cereal compounds after eating 6 different types of cereal preparation, with a focus on alkylresorcinols.
Looking for future studies?
Notify Me18 year–55 year
All sexes
Interventional
Not applicable
Lausanne, Canton of Vaud, 1000, Switzerland
This was a cross-over, randomized, double blind study with 6 arms (flours of different composition). Thirteen subjects completed the trial, where 100 g of each flour, mixed with 300 mL milk, was fed to all subjects.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
A treated cereal flour mixed with milk.
A treated cereal flour mixed with milk.
A treated cereal flour mixed with milk.
A treated cereal flour mixed with milk.
A treated cereal flour mixed with milk.
A treated cereal flour mixed with milk.
Time frame: From 0 to 48 h post dose.
Area under the curve (AUC) over baseline of alkylresorcinol compounds are measured for the 6 interventional arms. Time points are: t = 0.5, 1, 2, 3, 4, 5, 6, 7, 8, 10, 12, 14, 24 and 48 h after product intake.
Time frame: From 0 to 48 hours post dose
Time frame: 0-48 h post dose
Phenolic acids in plasma and urine
Société des Produits Nestlé (SPN)
Industry
Response of Alkylresorcinols and Other Biomarkers to Different Cereals
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06068257
Breast Cancer, Breast Diseases
Orlando, Florida, United States
View Trial DetailsNCT06702423
Healthy
London, United Kingdom
View Trial DetailsNCT07223164
Healthy
Irvine, California, United States
View Trial DetailsNCT05595902
Healthy
Kadıköy, Istanbul, Turkey (Türkiye)
View Trial Details